Shopping Cart 0
Cart Subtotal
AED 0

Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258

Details

Summary

Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Ypsomed Holding AG

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Ypsomed Holding AG Company Overview

Ypsomed Holding AG Company Snapshot

Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview

Ypsomed Holding AG-Pipeline Analysis Overview

Business Description

Ypsomed Holding AG-Key Facts

Ypsomed Holding AG-Major Products and Services

Ypsomed Holding AG Pipeline Products by Development Stage

Ypsomed Holding AG Pipeline Products Overview

Lanzi

Lanzi Product Overview

mylife YpsoPod Insulin Pump-Tubeless

mylife YpsoPod Insulin Pump-Tubeless Product Overview

mylife YpsoPump

mylife YpsoPump Product Overview

mylife YpsoPump 2.0 With Integrated CGM

mylife YpsoPump 2.0 With Integrated CGM Product Overview

YpsoDose

YpsoDose Product Overview

Ypsomed Holding AG-Key Competitors

Ypsomed Holding AG-Key Employees

Ypsomed Holding AG-Key Employee Biographies

Ypsomed Holding AG-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Ypsomed Holding AG, Recent Developments

Nov 05, 2019: Ypsomed grows strongly in the pen business

Aug 30, 2019: Ypsomed expands headquarters in Burgdorf

Aug 22, 2019: Ypsomed opens production plant in Schwerin

May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability

May 07, 2019: Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed

May 01, 2019: Noble continues to elevate patient access with launch of Its innovative YpsoMate Training Device Platform

Feb 14, 2019: NFC-Label by Schreiner MediPharm for Ypsomed's SmartPilot supports smart self-medication

Nov 06, 2018: Ypsomed grows strongly with own products

Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin

Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Ypsomed Holding AG Pipeline Products by Equipment Type

Ypsomed Holding AG Pipeline Products by Development Stage


List Of Table

List of Tables

Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview

Ypsomed Holding AG Pipeline Products by Equipment Type

Ypsomed Holding AG Pipeline Products by Indication

Ypsomed Holding AG, Key Facts

Ypsomed Holding AG, Major Products and Services

Ypsomed Holding AG Number of Pipeline Products by Development Stage

Ypsomed Holding AG Pipeline Products Summary by Development Stage

Lanzi-Product Status

Lanzi-Product Description

mylife YpsoPod Insulin Pump-Tubeless-Product Status

mylife YpsoPod Insulin Pump-Tubeless-Product Description

mylife YpsoPump-Product Status

mylife YpsoPump-Product Description

mylife YpsoPump 2.0 With Integrated CGM-Product Status

mylife YpsoPump 2.0 With Integrated CGM-Product Description

YpsoDose-Product Status

YpsoDose-Product Description

Ypsomed Holding AG, Key Employees

Ypsomed Holding AG, Key Employee Biographies

Ypsomed Holding AG, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Ypsomed Holding AG, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Sanofi

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Johnson & Johnson

Novo Nordisk AS

Abbott Laboratories

Medtronic Plc

Summary

Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Ypsomed Holding AG

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Ypsomed Holding AG Company Overview

Ypsomed Holding AG Company Snapshot

Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview

Ypsomed Holding AG-Pipeline Analysis Overview

Business Description

Ypsomed Holding AG-Key Facts

Ypsomed Holding AG-Major Products and Services

Ypsomed Holding AG Pipeline Products by Development Stage

Ypsomed Holding AG Pipeline Products Overview

Lanzi

Lanzi Product Overview

mylife YpsoPod Insulin Pump-Tubeless

mylife YpsoPod Insulin Pump-Tubeless Product Overview

mylife YpsoPump

mylife YpsoPump Product Overview

mylife YpsoPump 2.0 With Integrated CGM

mylife YpsoPump 2.0 With Integrated CGM Product Overview

YpsoDose

YpsoDose Product Overview

Ypsomed Holding AG-Key Competitors

Ypsomed Holding AG-Key Employees

Ypsomed Holding AG-Key Employee Biographies

Ypsomed Holding AG-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Ypsomed Holding AG, Recent Developments

Nov 05, 2019: Ypsomed grows strongly in the pen business

Aug 30, 2019: Ypsomed expands headquarters in Burgdorf

Aug 22, 2019: Ypsomed opens production plant in Schwerin

May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability

May 07, 2019: Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed

May 01, 2019: Noble continues to elevate patient access with launch of Its innovative YpsoMate Training Device Platform

Feb 14, 2019: NFC-Label by Schreiner MediPharm for Ypsomed's SmartPilot supports smart self-medication

Nov 06, 2018: Ypsomed grows strongly with own products

Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin

Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Ypsomed Holding AG Pipeline Products by Equipment Type

Ypsomed Holding AG Pipeline Products by Development Stage


List Of Table

List of Tables

Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview

Ypsomed Holding AG Pipeline Products by Equipment Type

Ypsomed Holding AG Pipeline Products by Indication

Ypsomed Holding AG, Key Facts

Ypsomed Holding AG, Major Products and Services

Ypsomed Holding AG Number of Pipeline Products by Development Stage

Ypsomed Holding AG Pipeline Products Summary by Development Stage

Lanzi-Product Status

Lanzi-Product Description

mylife YpsoPod Insulin Pump-Tubeless-Product Status

mylife YpsoPod Insulin Pump-Tubeless-Product Description

mylife YpsoPump-Product Status

mylife YpsoPump-Product Description

mylife YpsoPump 2.0 With Integrated CGM-Product Status

mylife YpsoPump 2.0 With Integrated CGM-Product Description

YpsoDose-Product Status

YpsoDose-Product Description

Ypsomed Holding AG, Key Employees

Ypsomed Holding AG, Key Employee Biographies

Ypsomed Holding AG, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Ypsomed Holding AG, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Sanofi

F. Hoffmann-La Roche Ltd

Eli Lilly and Co

Johnson & Johnson

Novo Nordisk AS

Abbott Laboratories

Medtronic Plc